Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

AbbVie (NY:ABBV)

190.72 -1.69 (-0.88%)
Streaming Delayed Price Updated: 2:40 PM EDT, Jun 13, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2,423,640
Open 191.56
Bid (Size) 190.63 (2)
Ask (Size) 190.82 (1)
Prev. Close 192.42
Today's Range 190.38 - 193.47
52wk Range 163.52 - 218.66
Shares Outstanding N/A
Dividend Yield 3.44%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
How Is The Market Feeling About AbbVie?
Via Benzinga
AbbVie Stock Rises After FDA Approves Expanded Treatment Scope For Mavyret, But Retail Needs More To Cheer
The approval makes Mavyret the first and only oral eight-week direct-acting antiviral therapy for people with Acute Hepatitis C Virus. 
Via Stocktwits
Exposures Product Safety

Performance

YTD
+6.3%
+6.3%
1 Month
+1.4%
+1.4%
3 Month
-9.8%
-9.8%
6 Month
+10.1%
+10.1%
1 Year
+14.8%
+14.8%

More News

Read More
FDA Expands AbbVie's Mavyret Label To Include Pediatric Patients With Hepatitis C Infection
Via Benzinga
Exposures Product Safety
Recent Filing Shows That Rep. Robert Bresnahan Bought Over $28K Worth of AbbVie Stock
Via Benzinga
1 S&P 500 Stock with Competitive Advantages and 2 to Steer Clear Of
Via StockStory
Topics Economy Stocks
Exposures Supply Chain US Equities
3 Stocks With Mouthwatering Dividends You Can Buy Right Now
Via The Motley Fool
Topics Intellectual Property
Exposures Intellectual Property
Billionaire Ken Griffin Just Bought More Shares of These Unstoppable Dividend Stocks
Via The Motley Fool
Topics Economy World Trade
Exposures Economy Tariff
AnaptysBio's Arthritis Drug Matches Top Therapies In Phase 2 Trial, Analyst Sees Turning Point
Via Benzinga
9 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
3 Cheap Dividend Growth Stocks to Buy Right Now
Via The Motley Fool
Topics Economy
Exposures Interest Rates
4 Forever Dividend Stocks to Buy
Via The Motley Fool
Meta, JPMorgan, Gap And A Health Care Stock On CNBC's 'Final Trades'
Via Benzinga
Novo Nordisk Is Shedding Muscle In The Weight-Loss Brawl With Eli Lilly
Via Investor's Business Daily
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
AbbVie To Present Cancer Trial Data At Upcoming ASCO Event
Via Benzinga
U.S. Pharmaceutical Imports Might Soon Face Tariffs: 3 Stocks That Could Tumble as a Result
Via The Motley Fool
Topics Government Supply Chain World Trade
Exposures Political Supply Chain Tariff
Elon Musk Commits to Tesla. Is That a Good Thing?
Via The Motley Fool
2 Incredible Dividend Growth Stocks to Buy Now
Via The Motley Fool
Topics Government Intellectual Property
Exposures Intellectual Property Political
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Don't Fall for These 3 Dividend Stocks: They May Have to Make a Cut.
Via The Motley Fool
Exposures COVID-19
3 Magnificent Stocks That Are Passive Income Machines
Via The Motley Fool
3 Stocks That Will Profit From Trump's Drug Price Cut
Via Benzinga
Topics Government
Exposures Political
1 Healthcare Stock to Keep an Eye On and 2 to Ignore
Via StockStory
Topics Economy Stocks
Exposures COVID-19 Supply Chain US Equities
Why Pfizer Is Poised For A Strong Comeback: My Top Pick For 2025
Via Benzinga

Frequently Asked Questions

Is AbbVie publicly traded?
Yes, AbbVie is publicly traded.
What exchange does AbbVie trade on?
AbbVie trades on the New York Stock Exchange
What is the ticker symbol for AbbVie?
The ticker symbol for AbbVie is ABBV on the New York Stock Exchange
What is the current price of AbbVie?
The current price of AbbVie is 190.72
When was AbbVie last traded?
The last trade of AbbVie was at 06/13/25 02:40 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.